Fig. 2
From: Nanocell-mediated delivery of miR-34a counteracts temozolomide resistance in glioblastoma
Overexpression of miR-34a inhibits glioblastoma cell proliferation. Glioblastoma cell cultures were reverse-transfected with 0–30 nM miR-34a or 30 nM control miRNA which served as the control condition. Cell proliferation was quantified by SRB assay 4 days post-transfection. All data represent mean SRB values of miR-34a transfected wells as a percentage of control transfected wells (± SD) from three independent experiments